• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Medclair

2.89 SEK-1.70 %27.7, 14.30
Less than 1K followers

MCLR

NGM Growth Market

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Compare
-1.70 %
+26.20 %
+24.57 %
+0.35 %
-3.02 %
+25.65 %
+135.34 %
-9.40 %
+1.20 %

Medclair is a Swedish cleantech company that develops technology for sustainable handling of nitrous oxide in healthcare, recycling and other industries using nitrous oxide. The company has an established international presence and offers solutions that aim to both reduce climate impact and improve the working environment. The headquarters are located in Stockholm.

Read more
Market cap
264.86M SEK
Turnover
74.62K SEK
Revenue
52.08M
EBIT %
9.86 %
P/E
48.17
Dividend yield-%
-
Revenue and EBIT-%
EPS and dividend
Financial calendar
20.8
2026

Interim report Q2'26

5.11
2026

Interim report Q3'26

All
Press releases
ShowingAll content types

Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Press release13.07.2026, 08.00

Medclair secures exclusive framework agreement with French purchasing center Resah

Medclair
Regulatory press release09.07.2026, 08.45

Medclair merges subsidiary and updates patent valuation – expected to generate a positive one-off effect of approximately MSEK 30

Medclair
Press release03.07.2026, 08.00

Medclair clarifies framework agreement with Folktandvården – contract value 6 MSEK

Medclair

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Press release02.07.2026, 11.10

SUEZ highlights Medclair’s technology in French project

Medclair
Press release01.07.2026, 08.00

Medclair adds a new recycling customer in France

Medclair
Press release30.06.2026, 08.00

Folktandvården in Region Stockholm signs a framework agreement with Medclair

Medclair
Press release26.06.2026, 08.00

Medclair's Danish growth continues – secures order from a new region

Medclair
Press release12.06.2026, 08.00

The first order for mobile systems in Denmark demonstrates the strength of Medclair's growth model

Medclair
Press release04.06.2026, 14.00

Medclair strengthens the organization with key expertise in marketing and finance

Medclair
Press release28.05.2026, 08.00

Medclair strengthens its position in French recycling – new deals and increased demand

Medclair
Regulatory press release07.05.2026, 08.00

MEDCLAIR INTERIM REPORT JANUARY–MARCH 2026

Medclair
Press release05.05.2026, 13.00

Medclair Lowers Barriers to Global Billion-Scale Market – New Technology Accelerates Expansion and Strengthens Market Position

Medclair
Press release05.05.2026, 10.10

Medclair: Q1 2026 Interim Report Presentation

Medclair
Press release29.04.2026, 10.40

Medclair's technology enables compliance with strict new limit values – independent French study confirms results

Medclair
Regulatory press release22.04.2026, 18.05

Communiqué from the Annual General Meeting of Medclair AB

Medclair
Press release22.04.2026, 09.30

Veolia chooses Medclair for nitrous oxide destruction in new market

Medclair
Regulatory press release19.04.2026, 11.20

Medclair AB – Nomination Committee’s Proposal

Medclair
Press release14.04.2026, 15.00

Medclair featured in French national media

Medclair
Regulatory press release01.04.2026, 17.31

Medclair - Annual Report 2025

Medclair
Press release31.03.2026, 13.45

Medclair secures dual patents for new technology in nitrous oxide management

Medclair